Stock Evaluator: AngioDynamics, Inc. (ANGO)

AngioDynamics, Inc. ANGO

$15.75 -0.07 -0.44%
August 21, 2026 4:00:00 PM EST November 10, 2021 Volume: 150,065
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers’ off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Commentary & Analysis


Financial Summary

Share Statistics ANGO Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $653.9 $407.7 40%
Shares Out (Mil) 41.7 41.3 43%
Institutional Ownership 88.4% 81.4% 56%
Float (Mil) 31.8 34.9 37%
Beta 0.34 0.88 20%
Avg Daily Volume (000s) 440 412 56%
Price Change
(52-week)
79.2% 64.8% 87%
Growth ANGO Industry
Median
Percentile
(All Stocks)
Sales (5yr) 1.9% 11.8% 23%
Net Income (5yr) (3.1%) (6.0%) 36%
EPS (5yr) (1.5%) 10.4% 29
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 20.8% (16.2%) 80%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 2
Current EPS ($0.113) ($0.267) ($0.045)
Month Ago EPS ($0.113) ($0.267) ($0.045)
# Rev Up 0 0 0
# Rev Down 1 1 1
Three Months Ago EPS ($0.097) ($0.220) ($0.030)
Year/Year Chg (58.8%) (69.8%) (124.9%)
Financials ANGO Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $320 $119 36%
Net Income (TTM) (Mil) ($37) ($9) 19%
EPS (TTM) ($0.885) ($0.400) 22%
Operating Cash Flow (TTM) (Mil) $3 ($3) 35%
Net Cash Flow (TTM) (Mil) ($2) $1 37%
Long-Term Debt (Q1) (Mil) $9 $21 28%
Enterprise Value (Q1) (Mil) $542 $427 35%
Valuation ANGO Industry
Median
Percentile
(All Stocks)
P/B 3.86 3.06 72%
P/E na 27.8 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.7 na
Ratios ANGO Industry
Median
Percentile
(All Stocks)
Gross Margin 54.6% 58.9% 66%
Net Margin (11.5%) (6.9%) 20%
ROA (13.4%) (12.7%) 23%
ROE (20.8%) (13.1%) 23%
Liabilities to Assets 36.1% 46.0% 27%
F-Score 4 4 34%

AngioDynamics, Inc. did not pass any screens on 8/20/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors